{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:42:05Z","timestamp":1784119325086,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460265"],"award-info":[{"award-number":["82460265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Health and Wellness Innovation Talent Project of Jiangxi Province's \"Gan po Talent Program\"","award":["gpyc20240210"],"award-info":[{"award-number":["gpyc20240210"]}]},{"name":"Key Project of Scientific and Technological Innovation of Jiangxi Provincial Health Commission","award":["2025ZD005"],"award-info":[{"award-number":["2025ZD005"]}]},{"name":"Yang Fan Project of the First Affiliated Hospital of Nanchang University","award":["RSC-0036"],"award-info":[{"award-number":["RSC-0036"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02475-w","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:24:13Z","timestamp":1773483853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanistic of LRRK2-Mediated Pyroptosis Via the NLRP3\/Caspase-1\/GSDMD Pathway in Parkinson\u2019s Disease Progression"],"prefix":"10.1007","volume":"49","author":[{"given":"Jianwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"2475_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A., and M. A. Schwarzschild. 2016. The epidemiology of parkinson\u2019s disease: Risk factors and prevention. Lancet Neurology 15:1257\u20131272.","journal-title":"Lancet Neurology"},{"key":"2475_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau, L. M., and M. M. Breteler. 2006. Epidemiology of parkinson\u2019s disease. Lancet Neurology 5:525\u2013535.","journal-title":"Lancet Neurology"},{"key":"2475_CR3","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1007\/s00415-024-12477-z","volume":"271","author":"HS Yoo","year":"2024","unstructured":"Yoo, H. S., H. K. Kim, H. S. Lee, S. H. Yoon, H. K. Na, S. W. Kang, J. H. Lee, Y. H. Ryu, and C. H. Lyoo. 2024. Predictors associated with the rate of progression of nigrostriatal degeneration in parkinson\u2019s disease. Journal of Neurology 271:5213\u20135222.","journal-title":"Journal of Neurology"},{"key":"2475_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/mds.21429","volume":"22","author":"A Schrag","year":"2007","unstructured":"Schrag, A., R. Dodel, A. Spottke, B. Bornschein, U. Siebert, and N. P. Quinn. 2007. Rate of clinical progression in parkinson\u2019s disease. A prospective study. Movement Disorders 22:938\u2013945.","journal-title":"Movement Disorders"},{"key":"2475_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao, C., J. Jiang, Y. Tan, and S. Chen. 2023. Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets. Signal Transduct Target Ther 8:359.","journal-title":"Signal Transduct Target Ther"},{"key":"2475_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.immuni.2021.01.013","volume":"54","author":"RT Han","year":"2021","unstructured":"Han, R. T., R. D. Kim, A. V. Molofsky, and S. A. Liddelow. 2021. Astrocyte-immune cell interactions in physiology and pathology. Immunity 54:211\u2013224.","journal-title":"Immunity"},{"key":"2475_CR7","doi-asserted-by":"crossref","unstructured":"Ransohoff, R. M., D. Schafer, A. Vincent, N. E. Blach\u00e8re, and A. Bar-Or. 2015. Neuroinflammation: Ways in which the immune system affects the brain. Neurotherapeutics 12:896\u2013909.","DOI":"10.1007\/s13311-015-0385-3"},{"key":"2475_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G., R. L. Wallings, M. C. Houser, M. K. Herrick, C. E. Keating, and V. Joers. 2022. Inflammation and immune dysfunction in Parkinson disease. Nature Reviews Immunology 22:657\u2013673.","journal-title":"Nature Reviews Immunology"},{"key":"2475_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., D. Xiao, Q. Mao, and H. Xia. 2023. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267.","journal-title":"Signal Transduct Target Ther"},{"key":"2475_CR10","doi-asserted-by":"crossref","unstructured":"Marogianni, C., M. Sokratous, E. Dardiotis, G. M. Hadjigeorgiou, D. Bogdanos, and G. Xiromerisiou. 2020. Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease. International Journal of Molecular Sciences 21(22):8421.","DOI":"10.3390\/ijms21228421"},{"key":"2475_CR11","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"DC Wu","year":"2003","unstructured":"Wu, D. C., P. Teismann, K. Tieu, M. Vila, V. Jackson-Lewis, H. Ischiropoulos, and S. Przedborski. 2003. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinson\u2019s disease. Proc Natl Acad Sci U S A 100:6145\u20136150.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2475_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.03-0983fje","volume":"18","author":"W Zhang","year":"2004","unstructured":"Zhang, W., T. Wang, L. Qin, H. M. Gao, B. Wilson, S. F. Ali, W. Zhang, J. S. Hong, and B. Liu. 2004. Neuroprotective effect of dextromethorphan in the MPTP parkinson\u2019s disease model: Role of NADPH oxidase. Faseb J 18:589\u2013591.","journal-title":"Faseb J"},{"key":"2475_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel, P. P., E. C. Hirsch, and S. Hunot. 2016. Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90:675\u2013691.","journal-title":"Neuron"},{"issue":"Suppl","key":"2475_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/nm1067","volume":"10","author":"E Bossy-Wetzel","year":"2004","unstructured":"Bossy-Wetzel, E., R. Schwarzenbacher, and S. A. Lipton. 2004. Molecular pathways to neurodegeneration. Nature Medicine 10(Suppl):2\u20139.","journal-title":"Nature Medicine"},{"key":"2475_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen, X., C. Yong, X. Yang, S. Chen-Yu, and P. Li-Hua. 2023. Signaling pathways in parkinson\u2019s disease: Molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8:73.","journal-title":"Signal Transduct Target Ther"},{"key":"2475_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41531-022-00367-y","volume":"8","author":"T Tezuka","year":"2022","unstructured":"Tezuka, T., D. Taniguchi, M. Sano, T. Shimada, Y. Oji, T. Tsunemi, A. Ikeda, Y. Li, H. Yoshino, J. Ogata, K. Shiba-Fukushima, M. Funayama, K. Nishioka, Y. Imai, and N. Hattori. 2022. Pathophysiological evaluation of the LRRK2 G2385R risk variant for parkinson\u2019s disease. NPJ Parkinsons Dis 8:97.","journal-title":"NPJ Parkinsons Dis"},{"key":"2475_CR17","doi-asserted-by":"crossref","unstructured":"Myasnikov, A., H. Zhu, P. Hixson, B. Xie, K. Yu, A. Pitre, J. Peng, and J. Sun. 2021. Structural analysis of the full-length human LRRK2. Cell 184:3519\u20133527.e3510.","DOI":"10.1016\/j.cell.2021.05.004"},{"key":"2475_CR18","doi-asserted-by":"crossref","unstructured":"Watanabe, R., R. Buschauer, J. B\u00f6hning, M. Audagnotto, K. Lasker, T. W. Lu, D. Boassa, S. Taylor, and E. Villa. 2020. The in situ structure of Parkinson\u2019s disease-linked LRRK2. Cell 182:1508\u20131518.e1516.","DOI":"10.1016\/j.cell.2020.08.004"},{"key":"2475_CR19","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/acn3.51776","volume":"10","author":"YL Sosero","year":"2023","unstructured":"Sosero, Y. L., and Z. Gan-Or. 2023. LRRK2 and parkinson\u2019s disease: From genetics to targeted therapy. Annals of Clinical and Translational Neurology 10:850\u2013864.","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"2475_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcdb.2019.05.022","volume":"98","author":"M Abate","year":"2020","unstructured":"Abate, M., A. Festa, M. Falco, A. Lombardi, A. Luce, A. Grimaldi, S. Zappavigna, P. Sperlongano, C. Irace, M. Caraglia, and G. Misso. 2020. Mitochondria as playmakers of apoptosis, autophagy and senescence. Seminars in Cell & Developmental Biology 98:139\u2013153.","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"2475_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz, P., P. Pelegr\u00edn, and F. Shao. 2020. The gasdermins, a protein family executing cell death and inflammation. Nature Reviews Immunology 20:143\u2013157.","journal-title":"Nature Reviews Immunology"},{"key":"2475_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/cr.2016.100","volume":"26","author":"X Chen","year":"2016","unstructured":"Chen, X., W. T. He, L. Hu, J. Li, Y. Fang, X. Wang, X. Xu, Z. Wang, K. Huang, and J. Han. 2016. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Research 26:1007\u20131020.","journal-title":"Cell Research"},{"key":"2475_CR23","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He, W. T., H. Wan, L. Hu, P. Chen, X. Wang, Z. Huang, Z. H. Yang, C. Q. Zhong, and J. Han. 2015. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Research 25:1285\u20131298.","journal-title":"Cell Research"},{"key":"2475_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J., Y. Zhao, K. Wang, X. Shi, Y. Wang, H. Huang, Y. Zhuang, T. Cai, F. Wang, and F. Shao. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526:660\u2013665.","journal-title":"Nature"},{"key":"2475_CR25","doi-asserted-by":"publisher","first-page":"167379","DOI":"10.1016\/j.jmb.2021.167379","volume":"434","author":"Y Hu","year":"2022","unstructured":"Hu, Y., B. Wang, S. Li, and S. Yang. 2022. Pyroptosis, and its role in central nervous system disease. Journal of Molecular Biology 434:167379.","journal-title":"Journal of Molecular Biology"},{"key":"2475_CR26","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1073\/pnas.1607769113","volume":"113","author":"RA Aglietti","year":"2016","unstructured":"Aglietti, R. A., A. Estevez, A. Gupta, M. G. Ramirez, P. S. Liu, N. Kayagaki, C. Ciferri, V. M. Dixit, and E. C. Dueber. 2016. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci U S A 113:7858\u20137863.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2475_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N., I. B. Stowe, B. L. Lee, K. O\u2019Rourke, K. Anderson, S. Warming, T. Cuellar, B. Haley, M. Roose-Girma, Q. T. Phung, P. S. Liu, J. R. Lill, H. Li, J. Wu, S. Kummerfeld, J. Zhang, W. P. Lee, S. J. Snipas, G. S. Salvesen, L. X. Morris, L. Fitzgerald, Y. Zhang, E. M. Bertram, C. C. Goodnow, and V. M. Dixit. 2015. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526:666\u2013671.","journal-title":"Nature"},{"key":"2475_CR28","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1084\/jem.20180589","volume":"215","author":"BL Lee","year":"2018","unstructured":"Lee, B. L., I. B. Stowe, A. Gupta, O. S. Kornfeld, M. Roose-Girma, K. Anderson, S. Warming, J. Zhang, W. P. Lee, and N. Kayagaki. 2018. Caspase-11 auto-proteolysis is crucial for noncanonical inflammasome activation. Journal of Experimental Medicine 215:2279\u20132288.","journal-title":"Journal of Experimental Medicine"},{"key":"2475_CR29","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20172060","volume":"215","author":"A Kanneganti","year":"2018","unstructured":"Kanneganti, A., R. K. S. Malireddi, P. H. V. Saavedra, L. Vande Walle, H. Van Gorp, H. Kambara, H. Tillman, P. Vogel, H. R. Luo, R. J. Xavier, H. Chi, and M. Lamkanfi. 2018. GSDMD is critical for autoinflammatory pathology in a mouse model of Familial mediterranean fever. Journal of Experimental Medicine 215:1519\u20131529.","journal-title":"Journal of Experimental Medicine"},{"key":"2475_CR30","doi-asserted-by":"publisher","first-page":"eaaz6717","DOI":"10.1126\/sciadv.aaz6717","volume":"6","author":"C Ma","year":"2020","unstructured":"Ma, C., D. Yang, B. Wang, C. Wu, Y. Wu, S. Li, X. Liu, K. Lassen, L. Dai, and S. Yang. 2020. Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation. Science Advances 6:eaaz6717.","journal-title":"Science Advances"},{"key":"2475_CR31","doi-asserted-by":"publisher","first-page":"e3000047","DOI":"10.1371\/journal.pbio.3000047","volume":"16","author":"J Xiao","year":"2018","unstructured":"Xiao, J., C. Wang, J. C. Yao, Y. Alippe, C. Xu, D. Kress, R. Civitelli, Y. Abu-Amer, T. D. Kanneganti, D. C. Link, and G. Mbalaviele. 2018. Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice. Plos Biology 16:e3000047.","journal-title":"Plos Biology"},{"key":"2475_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","volume":"68","author":"B Xu","year":"2018","unstructured":"Xu, B., M. Jiang, Y. Chu, W. Wang, D. Chen, X. Li, Z. Zhang, D. Zhang, D. Fan, Y. Nie, F. Shao, K. Wu, and J. Liang. 2018. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. Journal of Hepatology 68:773\u2013782.","journal-title":"Journal of Hepatology"},{"key":"2475_CR33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","volume":"22","author":"J Hou","year":"2020","unstructured":"Hou, J., R. Zhao, W. Xia, C. W. Chang, Y. You, J. M. Hsu, L. Nie, Y. Chen, Y. C. Wang, C. Liu, W. J. Wang, Y. Wu, B. Ke, J. L. Hsu, K. Huang, Z. Ye, Y. Yang, X. Xia, Y. Li, C. W. Li, B. Shao, J. A. Tainer, and M. C. Hung. 2020. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nature Cell Biology 22:1264\u20131275.","journal-title":"Nature Cell Biology"},{"key":"2475_CR34","doi-asserted-by":"crossref","unstructured":"Li, S., Y. Sun, M. Song, Y. Song, Y. Fang, Q. Zhang, X. Li, N. Song, J. Ding, M. Lu, and G. Hu. 2021. NLRP3\/caspase-1\/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression. JCI Insight 6.","DOI":"10.1172\/jci.insight.146852"},{"key":"2475_CR35","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","volume":"15","author":"X Han","year":"2019","unstructured":"Han, X., S. Sun, Y. Sun, Q. Song, J. Zhu, N. Song, M. Chen, T. Sun, M. Xia, J. Ding, M. Lu, H. Yao, and G. Hu. 2019. Small molecule-driven NLRP3 inflammation Inhibition via interplay between ubiquitination and autophagy: Implications for Parkinson disease. Autophagy 15:1860\u20131881.","journal-title":"Autophagy"},{"key":"2475_CR36","doi-asserted-by":"publisher","first-page":"111428","DOI":"10.1016\/j.biopha.2021.111428","volume":"138","author":"YS Feng","year":"2021","unstructured":"Feng, Y. S., Z. X. Tan, L. Y. Wu, F. Dong, and F. Zhang. 2021. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases. Biomedicine & Pharmacotherapy 138:111428.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2475_CR37","doi-asserted-by":"publisher","first-page":"e31250","DOI":"10.1002\/jcp.31250","volume":"239","author":"Z Zheng","year":"2024","unstructured":"Zheng, Z., S. Zhang, X. Liu, X. Wang, C. Xue, X. Wu, X. Zhang, X. Xu, Z. Liu, L. Yao, and G. Lu. 2024. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of parkinson\u2019s disease. Journal of Cellular Physiology 239:e31250.","journal-title":"Journal of Cellular Physiology"},{"key":"2475_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1021\/jm5014055","volume":"58","author":"JL Henderson","year":"2015","unstructured":"Henderson, J. L., B. L. Kormos, M. M. Hayward, K. J. Coffman, J. Jasti, R. G. Kurumbail, T. T. Wager, P. R. Verhoest, G. S. Noell, Y. Chen, E. Needle, Z. Berger, S. J. Steyn, C. Houle, W. D. Hirst, and P. Galatsis. 2015. Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. Journal of Medicinal Chemistry 58:419\u2013432.","journal-title":"Journal of Medicinal Chemistry"},{"key":"2475_CR39","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/ptr.3732","volume":"26","author":"P Magni","year":"2012","unstructured":"Magni, P., M. Ruscica, E. Dozio, E. Rizzi, G. Beretta, and R. Maffei Facino. 2012. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-\u03b1 and NF-\u03baB nuclear translocation in BV-2 microglia. Phytotherapy Research: Ptr 26:1405\u20131409.","journal-title":"Phytotherapy Research: Ptr"},{"key":"2475_CR40","doi-asserted-by":"publisher","first-page":"e0210248","DOI":"10.1371\/journal.pone.0210248","volume":"14","author":"J Kim","year":"2019","unstructured":"Kim, J., E. Pajarillo, A. Rizor, D. S. Son, J. Lee, M. Aschner, and E. Lee. 2019. LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia. PLoS One 14:e0210248.","journal-title":"PLoS One"},{"key":"2475_CR41","doi-asserted-by":"publisher","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","volume":"290","author":"JP Daher","year":"2015","unstructured":"Daher, J. P., H. A. Abdelmotilib, X. Hu, L. A. Volpicelli-Daley, M. S. Moehle, K. B. Fraser, E. Needle, Y. Chen, S. J. Steyn, P. Galatsis, W. D. Hirst, and A. B. West. 2015. Leucine-rich repeat kinase 2 (LRRK2) Pharmacological Inhibition abates \u03b1-Synuclein Gene-induced neurodegeneration. Journal of Biological Chemistry 290:19433\u201319444.","journal-title":"Journal of Biological Chemistry"},{"key":"2475_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-018-0049-1","volume":"4","author":"JH Kluss","year":"2018","unstructured":"Kluss, J. H., M. M. Conti, A. Kaganovich, A. Beilina, H. L. Melrose, M. R. Cookson, and A. Mamais. 2018. Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity. NPJ Parkinsons Dis 4:13.","journal-title":"NPJ Parkinsons Dis"},{"key":"2475_CR43","doi-asserted-by":"publisher","first-page":"164ra161","DOI":"10.1126\/scitranslmed.3004485","volume":"4","author":"Z Sheng","year":"2012","unstructured":"Sheng, Z., S. Zhang, D. Bustos, T. Kleinheinz, C. E. Le Pichon, S. L. Dominguez, H. O. Solanoy, J. Drummond, X. Zhang, X. Ding, F. Cai, Q. Song, X. Li, Z. Yue, M. P. van der Brug, D. J. Burdick, J. Gunzner-Toste, H. Chen, X. Liu, A. A. Estrada, Z. K. Sweeney, K. Scearce-Levie, J. G. Moffat, D. S. Kirkpatrick, and H. Zhu. 2012. Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations. Science Translational Medicine 4:164ra161.","journal-title":"Science Translational Medicine"},{"key":"2475_CR44","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1038\/s41598-021-85702-8","volume":"11","author":"YJ Wang","year":"2021","unstructured":"Wang, Y. J., A. Monteagudo, M. A. Downey, P. G. Ashton-Rickardt, and D. R. Elmaleh. 2021. Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3). Scientific Reports 11:8054.","journal-title":"Scientific Reports"},{"key":"2475_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12974-022-02511-0","volume":"19","author":"R Ding","year":"2022","unstructured":"Ding, R., H. Li, Y. Liu, W. Ou, X. Zhang, H. Chai, X. Huang, W. Yang, and Q. Wang. 2022. Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis. J Neuroinflammation 19:137.","journal-title":"J Neuroinflammation"},{"key":"2475_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1126\/science.aan4665","volume":"360","author":"MD Kornberg","year":"2018","unstructured":"Kornberg, M. D., P. Bhargava, P. M. Kim, V. Putluri, A. M. Snowman, N. Putluri, P. A. Calabresi, and S. H. Snyder. 2018. Dimethyl fumarate targets GAPDH and aerobic Glycolysis to modulate immunity. Science 360:449\u2013453.","journal-title":"Science"},{"key":"2475_CR47","doi-asserted-by":"publisher","first-page":"102938","DOI":"10.1016\/j.redox.2023.102938","volume":"68","author":"G Song","year":"2023","unstructured":"Song, G., J. Wang, J. Liu, and Y. Ruan. 2023. Dimethyl fumarate ameliorates erectile dysfunction in bilateral cavernous nerve injury rats by inhibiting oxidative stress and NLRP3 inflammasome-mediated pyroptosis of nerve via activation of Nrf2\/HO-1 signaling pathway. Redox Biology 68:102938.","journal-title":"Redox Biology"},{"key":"2475_CR48","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1042\/BST20160228","volume":"44","author":"MR Cookson","year":"2016","unstructured":"Cookson, M. R. 2016. Cellular functions of LRRK2 implicate vesicular trafficking pathways in parkinson\u2019s disease. Biochemical Society Transactions 44:1603\u20131610.","journal-title":"Biochemical Society Transactions"},{"key":"2475_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbrc.2018.02.007","volume":"498","author":"J Chen","year":"2018","unstructured":"Chen, J., P. Su, W. Luo, and J. Chen. 2018. Role of LRRK2 in manganese-induced neuroinflammation and microglial autophagy. Biochemical and Biophysical Research Communications 498:171\u2013177.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2475_CR50","doi-asserted-by":"publisher","first-page":"e13834","DOI":"10.1111\/acel.13834","volume":"22","author":"YQ Yan","year":"2023","unstructured":"Yan, Y. Q., R. Zheng, Y. Liu, Y. Ruan, Z. H. Lin, N. J. Xue, Y. Chen, B. R. Zhang, and J. L. Pu. 2023. Parkin regulates microglial NLRP3 and represses neurodegeneration in parkinson\u2019s disease. Aging Cell 22:e13834.","journal-title":"Aging Cell"},{"key":"2475_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mds.27874","volume":"35","author":"ME Haque","year":"2020","unstructured":"Haque, M. E., M. Akther, M. Jakaria, I. S. Kim, S. Azam, and D. K. Choi. 2020. Targeting the microglial NLRP3 inflammasome and its role in parkinson\u2019s disease. Movement Disorders 35:20\u201333.","journal-title":"Movement Disorders"},{"key":"2475_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ni.1703","volume":"10","author":"L Franchi","year":"2009","unstructured":"Franchi, L., T. Eigenbrod, R. Mu\u00f1oz-Planillo, and G. Nu\u00f1ez. 2009. The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nature Immunology 10:241\u2013247.","journal-title":"Nature Immunology"},{"key":"2475_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12950-015-0086-z","volume":"12","author":"EH Kim","year":"2015","unstructured":"Kim, E. H., M. J. Park, S. Park, and E. S. Lee. 2015. Increased expression of the NLRP3 inflammasome components in patients with Beh\u00e7et\u2019s disease. Journal of Inflammation (London) 12:41.","journal-title":"Journal of Inflammation (London)"},{"key":"2475_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao, B. Z., Z. Q. Xu, B. Z. Han, D. F. Su, and C. Liu. 2015. NLRP3 inflammasome and its inhibitors: A review. Frontiers in Pharmacology 6:262.","journal-title":"Frontiers in Pharmacology"},{"key":"2475_CR55","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd.2018.149","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M. S. J., E. J. Olhava, W. R. Roush, H. M. Seidel, G. D. Glick, and E. Latz. 2018. Targeting the NLRP3 inflammasome in inflammatory diseases. Nature Reviews. Drug Discovery 17:688.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"2475_CR56","doi-asserted-by":"crossref","unstructured":"Gordon, R., E. A. Albornoz, D. C. Christie, M. R. Langley, V. Kumar, S. Mantovani, A. A. B. Robertson, M. S. Butler, D. B. Rowe, L. A. O\u2019Neill, A. G. Kanthasamy, K. Schroder, M. A. Cooper, and T. M. Woodruff. 2018. Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in Mice. Science Translational Medicine 10(465).","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"2475_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee, E., I. Hwang, S. Park, S. Hong, B. Hwang, Y. Cho, J. Son, and J. W. Yu. 2019. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death and Differentiation 26:213\u2013228.","journal-title":"Cell Death and Differentiation"},{"key":"2475_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","volume":"4","author":"KM von Herrmann","year":"2018","unstructured":"von Herrmann, K. M., L. A. Salas, E. M. Martinez, A. L. Young, J. M. Howard, M. S. Feldman, B. C. Christensen, O. M. Wilkins, S. L. Lee, W. F. Hickey, and M. C. Havrda. 2018. NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of parkinson\u2019s disease. NPJ Parkinsons Dis 4:24.","journal-title":"NPJ Parkinsons Dis"},{"key":"2475_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha, E. M., B. De Miranda, and L. H. Sanders. 2018. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in parkinson\u2019s disease. Neurobiology of Diseases 109:249\u2013257.","journal-title":"Neurobiology of Diseases"},{"key":"2475_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.15684","volume":"179","author":"ME Haque","year":"2022","unstructured":"Haque, M. E., M. Akther, S. Azam, I. S. Kim, Y. Lin, Y. H. Lee, and D. K. Choi. 2022. Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in parkinson\u2019s disease. British Journal of Pharmacology 179:23\u201345.","journal-title":"British Journal of Pharmacology"},{"key":"2475_CR61","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik, D., C. Rosenblad, C. Burger, C. Lundberg, T. E. Johansen, N. Muzyczka, R. J. Mandel, and A. Bj\u00f6rklund. 2002. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. Journal of Neuroscience 22:2780\u20132791.","journal-title":"Journal of Neuroscience"},{"key":"2475_CR62","first-page":"188","volume":"18","author":"H Wood","year":"2022","unstructured":"Wood, H. 2022. \u03b1-Synuclein-activated microglia are implicated in PD pathogenesis. Nat Rev Neurol 18:188.","journal-title":"Nat Rev Neurol"},{"key":"2475_CR63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","volume":"12","author":"I Russo","year":"2015","unstructured":"Russo, I., G. Berti, N. Plotegher, G. Bernardo, R. Filograna, L. Bubacco, and E. Greggio. 2015. Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-\u03baB p50 signaling in cultured microglia cells. J Neuroinflammation 12:230.","journal-title":"J Neuroinflammation"},{"key":"2475_CR64","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey, M. G., and M. S. Goldberg. 2010. Neuroinflammation in parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiology of Diseases 37:510\u2013518.","journal-title":"Neurobiology of Diseases"},{"key":"2475_CR65","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","volume":"52","author":"D MacLeod","year":"2006","unstructured":"MacLeod, D., J. Dowman, R. Hammond, T. Leete, K. Inoue, and A. Abeliovich. 2006. The Familial parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52:587\u2013593.","journal-title":"Neuron"},{"key":"2475_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-022-00281-6","volume":"11","author":"SY Pang","year":"2022","unstructured":"Pang, S. Y., R. C. N. Lo, P. W. Ho, H. F. Liu, E. E. S. Chang, C. T. Leung, Y. Malki, Z. Y. Choi, W. Y. Wong, M. H. Kung, D. B. Ramsden, and S. L. Ho. 2022. LRRK2, GBA and their interaction in the regulation of autophagy: Implications on therapeutics in parkinson\u2019s disease. Transl Neurodegener 11:5.","journal-title":"Transl Neurodegener"},{"key":"2475_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","volume":"149","author":"H Sekiya","year":"2025","unstructured":"Sekiya, H., L. Franke, Y. Hashimoto, M. Takata, K. Nishida, N. Futamura, K. Hasegawa, H. Kowa, O. A. Ross, P. J. McLean, T. Toda, Z. K. Wszolek, and D. W. Dickson. 2025. Widespread distribution of \u03b1-synuclein oligomers in LRRK2-related parkinson\u2019s disease. Acta Neuropathologica 149:42.","journal-title":"Acta Neuropathologica"},{"key":"2475_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V., A. E. Lang, L. N. Hazrati, S. Fujioka, Z. K. Wszolek, D. W. Dickson, O. A. Ross, V. M. Van Deerlin, J. Q. Trojanowski, H. I. Hurtig, R. N. Alcalay, K. S. Marder, L. N. Clark, C. Gaig, E. Tolosa, J. Ruiz-Mart\u00ednez, J. F. Marti-Masso, I. Ferrer, A. de L\u00f3pez, S. M. Goldman, B. Sch\u00fcle, J. W. Langston, J. O. Aasly, M. T. Giordana, V. Bonifati, A. Puschmann, M. Canesi, G. Pezzoli, Maues De Paula, A. Hasegawa, K. Duyckaerts, C. Brice, A. Stoessl, A. J., and C. Marras. 2015. Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100\u2013105.","journal-title":"JAMA Neurol"},{"key":"2475_CR69","doi-asserted-by":"crossref","unstructured":"Gaig, C., M. J. Mart\u00ed, M. Ezquerra, A. Cardozo, M. J. Rey, and E. Tolosa. 2009. G2019S LRRK2 mutation causing Parkinson\u2019s disease without Lewy bodies. BMJ Case Rep 2009.","DOI":"10.1136\/bcr.08.2008.0632"},{"key":"2475_CR70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry, V. H., and C. Holmes. 2014. Microglial priming in neurodegenerative disease. Nat Rev Neurol 10:217\u2013224.","journal-title":"Nat Rev Neurol"},{"key":"2475_CR71","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi, M., M. Harada, P. Riederer, H. Narabayashi, K. Fujita, and T. Nagatsu. 1994. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neuroscience Letters 165:208\u2013210.","journal-title":"Neuroscience Letters"},{"key":"2475_CR72","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei, X., F. Xie, X. Zhou, Y. Wu, H. Yan, T. Liu, J. Huang, F. Wang, F. Zhou, and L. Zhang. 2022. Role of pyroptosis in inflammation and cancer. Cellular & Molecular Immunology 19:971\u2013992.","journal-title":"Cellular & Molecular Immunology"},{"key":"2475_CR73","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll, R. C., K. Schroder, and P. Pelegr\u00edn. 2022. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends in Pharmacological Sciences 43:653\u2013668.","journal-title":"Trends in Pharmacological Sciences"},{"key":"2475_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","volume":"119","author":"X Zhang","year":"2024","unstructured":"Zhang, X., Y. Zhang, B. Wang, C. Xie, J. Wang, R. Fang, H. Dong, G. Fan, M. Wang, Y. He, C. Shen, Y. Duan, J. Zhao, Z. Liu, Q. Li, Y. Ma, M. Yu, J. Wang, J. Fei, L. Xiao, and F. Huang. 2024. Pyroptosis-mediator GSDMD promotes parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death. Brain, Behavior, and Immunity 119:129\u2013145.","journal-title":"Brain, Behavior, and Immunity"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02475-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02475-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02475-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:02:23Z","timestamp":1774576943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02475-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2475"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02475-w","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All animal experiments in this study followed the \u201cGuidelines for Ethical Review of Welfare of Laboratory Animals in China\u201d (2018\/09) and the \u201cGuide for the Care and Use of Laboratory Animals.\u201d The study received full approval from the Ethics Committee of the First Affiliated Hospital of Nanchang University, with all procedures conducted under its strict supervision (Ethics Approval Number: CDYFY-IACUC-202409GR013).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}],"article-number":"118"}}